TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
Главный автор: | Feneberg, E |
---|---|
Другие авторы: | Turner, M |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
2019
|
Предметы: |
Схожие документы
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
по: Rachel H. Tan, и др.
Опубликовано: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
по: Yuhan Wu, и др.
Опубликовано: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
по: Piotr Włodarczyk, и др.
Опубликовано: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
по: Joanna Iłżecka
Опубликовано: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
по: Joanna Iłżecka
Опубликовано: (2017-12-01)